EUVIMEDEUVIMED entdecken
Crossref

Synthesis of New 26,27-Difluoro- and 26,26,27,27-Tetrafluoro-25-hydroxyvitamin D3: Effects of Terminal Fluorine Atoms on Biological Activity and Half-life

Fumihiro Kawagoe, Sayuri Mototani, Kaori Yasuda, Hiroki Mano, Akiko Takeuchi, Hiroshi Saitoh, Toshiyuki Sakaki, Atsushi Kittaka

Chemical and Pharmaceutical Bulletin · 2023

DOI: 10.1248/cpb.c23-00395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2023. Verfasst von Fumihiro Kawagoe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Teikyo University. Hauptthemen laut MEDLINE: Calcifediol, Calcitriol. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As an extension of our research on providing a chemical library of side-chain fluorinated vitamin D3 analogues, we newly designed and synthesized 26,27-difluoro-25-hydroxyvitamin D3 (1) and 26,26,27,27-tetrafluoro-25-hydroxyvitamin D3 (2) using a convergent method applying the Wittig-Horner coupling reaction between CD-ring ketones (13, 14) and A-ring phosphine oxide (5). The basic biological activities of analogues, 1, 2, and 26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D3 [HF-25(OH)D3] were examined. Although the tetrafluorinated new compound 2 exhibited higher binding affinity for vitamin D receptor (VDR) and resistance to CYP24A1-dependent metabolism compared with the difluorinated 1 and its non-fluorinated counterpart 25-hydroxyvitamin D3 [25(OH)D3], HF-25(OH)D3 showed the highest activity among these compounds. Osteocalcin promoter transactivation activity of these fluorinated analogues was tested, and it decreased in the order of HF-25(OH)D3, 2, 1, and 25(OH)D3 in which HF-25(OH)D3 showed 19-times greater activity than the natural 25(OH)D3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalcifediolCalcitriolFluorineHalf-LifeReceptors, CalcitriolVitamin D3 24-HydroxylaseVitamin D

Stichwörter der Autor:innen

CYP24A1side chain terminal fluorinated vitamin D3transcriptional activity

Substanzen

CalcifediolCalcitriolFluorineReceptors, CalcitriolVitamin D3 24-Hydroxylase25-hydroxyvitamin DVitamin D

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, Teikyo University.
  • Faculty of Engineering, Toyama Prefectural University.
  • Teijin Institute for Bio-medical Research, Teijin Pharma Ltd.

Zitieren

APA

Kawagoe, F., Mototani, S., Yasuda, K., Mano, H., Takeuchi, A., Saitoh, H., Sakaki, T., & Kittaka, A. (2023). Synthesis of New 26,27-Difluoro- and 26,26,27,27-Tetrafluoro-25-hydroxyvitamin D3: Effects of Terminal Fluorine Atoms on Biological Activity and Half-life. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c23-00395

Vancouver

Kawagoe F, Mototani S, Yasuda K, Mano H, Takeuchi A, Saitoh H, et al. Synthesis of New 26,27-Difluoro- and 26,26,27,27-Tetrafluoro-25-hydroxyvitamin D3: Effects of Terminal Fluorine Atoms on Biological Activity and Half-life. Chemical and Pharmaceutical Bulletin. 2023. doi:10.1248/cpb.c23-00395

BibTeX
@article{Kawagoe2023,
  author = {Kawagoe, Fumihiro and Mototani, Sayuri and Yasuda, Kaori and Mano, Hiroki and Takeuchi, Akiko and Saitoh, Hiroshi and Sakaki, Toshiyuki and Kittaka, Atsushi},
  title = {Synthesis of New 26,27-Difluoro- and 26,26,27,27-Tetrafluoro-25-hydroxyvitamin D3: Effects of Terminal Fluorine Atoms on Biological Activity and Half-life},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2023},
  doi = {10.1248/cpb.c23-00395}
}
Kostenlos starten →